Ketorolac Trometamol Brown & Burk Uk (Ketorolac Trometamol)

The drug reversibly inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in ocular tissues, which reduces prostaglandin synthesis. Lower prostaglandin levels decrease inflammation, vascular permeability, and pain signaling within the eye.

The dosing regimen for Ketorolac Trometamol eye drops is determined by the prescribing clinician based on the specific surgical procedure, severity of inflammation, and patient response. No fixed dose is provided here.

The safety of Ketorolac Trometamol in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketorolac Trometamol is a non‑steroidal anti‑inflammatory drug (NSAID) that provides anti‑inflammatory and analgesic effects without the steroid‑related side‑effects such as cataract formation. Compared with corticosteroid eye drops, it has a lower risk of intra‑ocular pressure elevation but may be less potent for severe inflammation.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from light and moisture, and ensure the cap is tightly closed to maintain sterility.

The solution is applied topically to the eye as directed by the prescriber, typically using one or two drops in the affected eye(s) at the prescribed interval. Patients should wash their hands before and after administration and avoid contaminating the dropper tip.

Serious risks include severe allergic reactions, corneal ulceration or perforation, and a significant increase in intra‑ocular pressure. Patients should seek immediate medical attention if they experience worsening vision, intense eye pain, or signs of an allergic response.

Individuals with known hypersensitivity to ketorolac, other NSAIDs, or any component of the formulation should avoid using the product. It is also contraindicated in patients with active ocular infections unless specifically advised by a healthcare professional.